FOLD FY 2012 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18M-14.1% YoY

Gross Profit

-$2M-10.7% margin

Operating Income

-$53M-287.5% margin

Net Income

-$49M-265.0% margin

EPS (Diluted)

$-1.07

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$38M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$110M

Total Liabilities

$41M

Stockholders' Equity

$69M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$21M	-14.1%
Gross Profit	-$2M	$21M	-109.2%
Operating Income	-$53M	-$51M	-4.0%
Net Income	-$49M	-$44M	-9.8%